Alexandra Tsioni

As the pharmaceutical industry strives for sustainability, regulatory frameworks governing clinical trial supplies often pose challenges that conflict with eco-friendly practices. This engaging, conference-wide debate will explore how regulatory requirements can adapt to facilitate sustainability while maintaining the integrity of clinical trials.

The session will address key issues, such as the transition to digital solutions, sustainability in labelling, and the environmental impact of product returns post-trial.